person · Reporting owner
Pellegrino Joseph P JR
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director | September 03, 2026 | September 08, 2026 |
| PRECISION OPTICS CORPORATION, INC.POCI · Entity 7237 | Director | November 17, 2025 | November 20, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 25.4682 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 25.4682 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 24.7852 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 2.1262 · Balance 24.7852 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 30.34 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 3.6322 · Balance 30.34 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 32.3815 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 4.3524 · Balance 32.3815 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 22.6745 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 3.9442 · Balance 22.6745 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 23.0295 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 4.4688 · Balance 23.0295 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 4.2988 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 1.6637 · Balance 4.2988 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
PRECISION OPTICS CORPORATION, INC.
Report date November 17, 2025 · Filed November 20, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Rights to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.33 · Expires 2035-11-17 | Direct | 30,000 |
Reported balance
After 2025-11-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-11-17 · Grant · Acquired 30,000 · Balance 30,000 F1: The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, subject to the reporting person remaining in the continuous employment of the Issuer through such applicable date. The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest in four equal installments on December 30, 2025, March 30, 2026, June 29, 2026, and September 29, 2026, subject to the reporting person remaining in the continuous employment of the Issuer through such applicable date. The options were granted under the Precision Optics Corporation, Inc. 2022 Equity Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 19, 2018 Filed Dec 21, 2018 21:09 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 21,832 | $0.00 Strike: $23.56 | $0.00 |
DisclosureSEC source: 0001209191-18-063893 · doc4.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,832 Underlying: Common Stock · 21,832 shares Expires 2025-12-19 F2 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| December 19, 2018 Filed Dec 21, 2018 21:09 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 2,653 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-063893 · doc4.xml · nonDerivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,164 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 20% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 21:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-061761 · doc4.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15 Underlying: Common Stock · 5 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 21:26 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-061761 · doc4.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54 Underlying: Common Stock · 7 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · shares: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 06, 2018 Filed Sep 10, 2018 20:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-050266 · doc4.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10 Underlying: Common Stock · 3 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · shares: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 06, 2018 Filed Sep 10, 2018 20:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-050266 · doc4.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47 Underlying: Common Stock · 5 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · shares: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 501 | $0.00 Strike: $6.23 | $0.00 |
DisclosureSEC source: 0001209191-18-048478 · doc4.xml · derivative · entry 3 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,060 Underlying: Common Stock · 501 shares Expires 2019-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 501 | $37.03 | $18,552.03 |
DisclosureSEC source: 0001209191-18-048478 · doc4.xml · nonDerivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,511 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $37.01 to $37.12. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 20:02 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 501 | $6.23 | $3,121.23 |
DisclosureSEC source: 0001209191-18-048478 · doc4.xml · nonDerivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 21:46 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 10 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-044263 · doc4.xml · derivative · entry 3 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42 Underlying: Common Stock · 10 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 21:46 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 264 | $37.36 | $9,863.04 |
DisclosureSEC source: 0001209191-18-044263 · doc4.xml · nonDerivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,511 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on July 25, 2016. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| July 25, 2018 Filed Jul 27, 2018 21:46 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 10 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-044263 · doc4.xml · nonDerivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 23:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,240 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0001209191-18-038680 · doc4.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,240 shares Expires 2018-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| June 15, 2018 Filed Jun 19, 2018 23:04 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 8,240 | $7.10 | $58,504.00 |
DisclosureSEC source: 0001209191-18-038680 · doc4.xml · nonDerivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-036671 · doc4.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7 Underlying: Common Stock · 4 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-036671 · doc4.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52 Underlying: Common Stock · 7 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 20:24 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-024330 · doc4.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3 Underlying: Common Stock · 3 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/22/2017 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| April 05, 2018 Filed Apr 9, 2018 20:24 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-024330 · doc4.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45 Underlying: Common Stock · 6 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 22, 2017 Filed Dec 28, 2017 01:37 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantStock Option (Right to Buy) · Derivative | 17,303 | $0.00 Strike: $31.30 | $0.00 |
DisclosureSEC source: 0001209191-17-067472 · doc4.xml · derivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,303 Underlying: Common Stock · 17,303 shares Expires 2024-12-22 F2 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. Read SEC document |
| December 22, 2017 Filed Dec 28, 2017 01:37 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 1,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-067472 · doc4.xml · nonDerivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,525 F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 20% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining four years. This award includes a provision for the withholding of shares by the Issuer to pay the withholding taxes due on each vesting date. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 21:32 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-065005 · doc4.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39 Underlying: Common Stock · 6 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 07, 2017 Filed Sep 11, 2017 20:48 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-052247 · doc4.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33 Underlying: Common Stock · 5 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| July 25, 2017 Filed Jul 28, 2017 01:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-046502 · doc4.xml · derivative · entry 3 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28 Underlying: Common Stock · 5 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on 7/25/2016. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| July 25, 2017 Filed Jul 28, 2017 01:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 289 | $28.58 | $8,259.62 |
DisclosureSEC source: 0001209191-17-046502 · doc4.xml · nonDerivative · entry 2 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,528 F2 · shares: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on July 25, 2016. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| July 25, 2017 Filed Jul 28, 2017 01:27 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 5 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-046502 · doc4.xml · nonDerivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 20:44 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-039187 · doc4.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33 Underlying: Common Stock · 7 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| April 06, 2017 Filed Apr 7, 2017 20:49 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-026290 · doc4.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26 Underlying: Common Stock · 9 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| December 05, 2016 Filed Dec 7, 2016 21:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-153879 · doc4.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17 Underlying: Common Stock · 8 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 21:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 9 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-140609 · doc4.xml · derivative · entry 1 Pellegrino Joseph P JR · CIK 0001365733 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9 Underlying: Common Stock · 9 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 7/25/2016 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.